Literature DB >> 21471711

Effects of Ginkgo biloba extract EGb761 on human colon adenocarcinoma cells.

Xue-Hong Chen1, Yuan-Xin Miao, Xiao-Ji Wang, Zhuang Yu, Mei-Yu Geng, Yan-Tao Han, Le-Xin Wang.   

Abstract

AIMS: To investigate the effect of Ginkgo biloba extract (EGb761) on cell proliferation and apoptosis in human colon cancer cells.
METHODS: Human colon cancer cell lines (HT-29) were cultured and incubated with various concentrations (0-320 mg/l) of EGb 761 solution for up to 72 h. Cell viability, cell apoptosis, cell cycle, expression of caspase-3, the mRNA levels of p53, and Bcl-2 were assessed.
RESULTS: EGb 761 inhibited the growth of HT-29 cells in a time-dose-dependent manner. At 80 and 320 mg/L, EGb 761 increased the number of cells in the G0/G1 phase and reduced cells in the G2/M and S phase. EGb 761 treatment also increased the apoptosis ratio of the HT-29 cells. EGb 761 treatment was associated with an increase in caspase-3 activities, reduction in bcl-2 mRNA expression and elevation in p53 mRNA expression.
CONCLUSION: EGb 761 inhibits the progression of human colon cancer cells. Its therapeutic effect may be related to enhanced caspase-3 activities, up-regulation of p53 and down-regulation of bcl-2 genes.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21471711     DOI: 10.1159/000327948

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  11 in total

1.  Effect of Ginkgo biloba extract on the expressions of Cox-2 and GST-Pi in rats with hepatocellular carcinoma risk.

Authors:  Chao Ou; Hai-Ping Zheng; Jian-Jia Su; Ji Cao; Guo-Jian Li; Le-Qun Li
Journal:  Afr Health Sci       Date:  2014-03       Impact factor: 0.927

2.  EGb-761 Attenuates the Anti-proliferative Activity of Fluoride via DDK1 in PC-12 Cells.

Authors:  Cai-Yi Zhang; Rui Chen; Fen Wang; Chao Ren; Peng Zhang; Qian Li; Hui-Hua Li; Ke-Tai Guo; De-Qin Geng; Chun-Feng Liu
Journal:  Neurochem Res       Date:  2016-11-25       Impact factor: 3.996

3.  Gingko biloba extract (Ginaton) ameliorates dextran sulfate sodium (DSS)-induced acute experimental colitis in mice via reducing IL-6/STAT3 and IL-23/IL-17.

Authors:  Yan Sun; Lian-Jie Lin; Yan Lin; Li-Xuan Sang; Min Jiang; Chang-Qing Zheng
Journal:  Int J Clin Exp Med       Date:  2015-10-15

4.  Ginkgo biloba extract 761 enhances 5-fluorouracil chemosensitivity in colorectal cancer cells through regulation of high mobility group-box 3 expression.

Authors:  Xi Chen; Lingbing Zeng
Journal:  Am J Transl Res       Date:  2018-06-15       Impact factor: 4.060

5.  Antiproliferative effect of the Ginkgo biloba extract is associated with the enhancement of cytochrome P450 1B1 expression in estrogen receptor-negative breast cancer cells.

Authors:  Xiao-Dan Zhao; Ni Dong; Hong-Tao Man; Zhong-Lin Fu; Mei-Hong Zhang; Shuang Kou; Shi-Liang Ma
Journal:  Biomed Rep       Date:  2013-07-22

6.  Ginkgo biloba extract decreases non-small cell lung cancer cell migration by downregulating metastasis-associated factor heat-shock protein 27.

Authors:  Jong-Rung Tsai; Po-Len Liu; Yung-Hsiang Chen; Shah-Hwa Chou; Ming-Chan Yang; Yu-Jen Cheng; Jhi-Jhu Hwang; Wei-Hsian Yin; Inn-Wen Chong
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

7.  Ginkgo biloba extract EGb 761-induced upregulation of LincRNA-p21 inhibits colorectal cancer metastasis by associating with EZH2.

Authors:  Tingting Liu; Junzhong Zhang; Zhongqiu Chai; Gang Wang; Naiqiang Cui; Bing Zhou
Journal:  Oncotarget       Date:  2017-09-27

Review 8.  Advances in the Studies of Ginkgo Biloba Leaves Extract on Aging-Related Diseases.

Authors:  Wei Zuo; Feng Yan; Bo Zhang; Jiantao Li; Dan Mei
Journal:  Aging Dis       Date:  2017-12-01       Impact factor: 6.745

9.  Ginkgo Biloba Extract Inhibits Metastasis and ERK/Nuclear Factor kappa B (NF-κB) Signaling Pathway in Gastric Cancer.

Authors:  Zhenhua Fu; Lan Lin; Shiquan Liu; Mengbin Qin; Siwei He; Liye Zhu; Jiean Huang
Journal:  Med Sci Monit       Date:  2019-09-11

Review 10.  Medicinal Plants in the Prevention and Treatment of Colon Cancer.

Authors:  Paola Aiello; Maedeh Sharghi; Shabnam Malekpour Mansourkhani; Azam Pourabbasi Ardekan; Leila Jouybari; Nahid Daraei; Khadijeh Peiro; Sima Mohamadian; Mahdiyeh Rezaei; Mahdi Heidari; Ilaria Peluso; Fereshteh Ghorat; Anupam Bishayee; Wesam Kooti
Journal:  Oxid Med Cell Longev       Date:  2019-12-04       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.